Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Aspen has reported a 15% drop in interim headline earnings per share. The drugmaker says the decline was mainly due to inflationary pressures, supply chain issues and the loss of Covid-19 vaccine sales. Business Day TV caught up with CEO Stephen Saad for more detail on the performance.
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
NEWS LEADER
WATCH: Aspen posts lower half-year profit
Business Day TV speaks to Aspen CEO Stephen Saad
Aspen has reported a 15% drop in interim headline earnings per share. The drugmaker says the decline was mainly due to inflationary pressures, supply chain issues and the loss of Covid-19 vaccine sales. Business Day TV caught up with CEO Stephen Saad for more detail on the performance.
Or listen to full audio
Subscribe for free episodes: iono.fm | Apple Podcasts | Spotify | Pocket Casts | Player.fm
Aspen’s shares surge on contract talks with multinationals
WATCH: SA banks take a knock after greylisting
WATCH: Cashbuild's profit slips as home renovation boom fizzles out
WATCH: Discovery withholds its interim dividend again
Companies in this Story
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.